Tag: clot

Classics Series, Landmark Trials in Medicine
This study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Medicine: Summaries of the Landmark Trials, 1e (The Classics Series). 1. Dalteparin, a low-molecular-weight heparin, is superior to warfarin in preventing recurrent venous thromboembolism in the setting of malignancy.  2. There is no significant difference in risk...
1. Patients who were admitted to the general medicine service for a short stay had a very low risk of developing a blood clot in their veins (venous thromboembolism).  2. Furthermore, the risk of developing a blood clot was not necessarily affected by the receipt of pharmacologic prophylaxis against blood clots at...